FDA Expands Palbociclib Approval for Male Breast Cancer
April 4th 2019The Food and Drug Administration (FDA) expanded the approved use of palbociclib (Ibrance) capsules plus endocrine therapy to treat male patients with hormone receptor (HR)–positive, HER2-negative advanced or metastatic breast cancer, according to an announcement by the agency.
Earlier, More Thorough Conversations Eases Distress in Advanced-Stage Patients
March 28th 2019Nurses and other healthcare providers can mitigate emotional distress and improve quality of life in patients with cancer by having earlier and more thorough conversations about their care, according to a recent study conducted at the Dana-Farber Cancer Institute.
FDA Proposes Changes to Negate Mammogram Oversight
March 27th 2019The FDA announced today that it is working to update mammography regulations, expanding the amount of information that mammography facilities must give patients and healthcare professionals. In turn, this would result in more informed decision-making – especially when it comes to breast cancer diagnoses.
Clinicians Must Address Financial Concerns With Patients
March 14th 2019Financial distress puts a major burden on patients with cancer and their families. And while there are numerous resources that nurses can share with their patients to help with co-pays and other money-related issues, they are not widely discussed.
Nurses Need a Comprehensive Approach for Hazardous Drug Handling
March 8th 2019In an interview with Oncology Nursing News, Christopher R. Friese, PhD, RN, AOCN, FAAN, discussed his study, and though the results were not what he expected, Friese still emphasized the need for proper education for oncology nurses.
A Review on Handling Hazardous Drugs
March 5th 2019When handling chemotherapy and other potentially dangerous anti-cancer drugs, there are steps that oncology nurses should take to protect themselves and their colleagues, according to a recent presscast from the American Society of Clinical Oncology (ASCO).
Young Patients With Colorectal Cancer Are Likely to Be Misdiagnosed
February 28th 2019Many younger patients see more than one doctor and face misdiagnoses before being given a diagnosis of colorectal cancer (CRC), according to recent research presented during a webcast ahead of the 2019 AACR Annual Meeting.